<DOC>
	<DOCNO>NCT00920608</DOCNO>
	<brief_summary>The main aim clinical study investigate whether blood concentration methotrexate change AZD9056 co- administer together methotrexate .</brief_summary>
	<brief_title>A Study Assess Pharmacokinetics Methotrexate Given With Without AZD9056 Rheumatoid Arthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Patients diagnose rheumatoid arthritis Currently Methotrexate treatment Provision inform consent History malignancy ( except treat squamous basal cell carcinoma skin 5 year prior entry ) Patients take prescription medication list : Medications hepatic enzyme inducer inhibitor cytochrome P450 , Lovastatin Leflunomide , hydroxychloroquine , cyclosporin antitumour necrosis factor therapy within 90 day Visit 1 , treatment rituximab within 1 year Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>AZD9056</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>interaction</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>